Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients
Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients
The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.
Inclusion Criteria:
Have Stages II to IVB head and neck cancer receiving radiation and may also be receiving chemotherapy.
* Subjects are eligible for inclusion in the study regardless of primary Stages II to IVB head and neck cancer treatment modality (eg, surgery, chemotherapy).
Have voluntarily signed and dated a written informed consent form (ICF) after the nature of the study was explained to them.
Female subjects must be of non childbearing potential (defined as postmenopausal for at least 1 year or surgically sterile [bilateral tubal ligation, bilateral oophorectomy or hysterectomy]) or;
Female subjects of childbearing potential must be using adequate contraception (practicing 1 of the following methods of birth control):
Female subjects must have a negative serum or urinary pregnancy test result at screening (serum specimen must be obtained within 14 days prior to baseline).
Exclusion Criteria: